Arrowhead Pharmaceuticals (0HI3.LSE) Q3 2024 Earnings

Aug 8Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.92
-1.44
-0.95
-0.47

Details

Expected EPS
-0.528927
Actual EPS
-1.38
Surprise EPS
-0.85
Surprise Percent
-160.91%

Description

⁨Arrowhead Pharmaceuticals⁩ (⁦0HI3.LSE⁩) has reported earnings of ⁦-1.38⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts